Shanghai MicroPort MedBot (Group) (HKG:2252) has obtained approval for its Toumai Single-arm and Single-port Laparoscopic Surgical Robot from China's National Medical Products Administration, a Tuesday Hong Kong bourse filing said.
The product is from the same series as the medical device company's core product, Toumai Laparoscopic Surgical Robot, which can complete complex surgeries with a minimally invasive approach.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.